Amedisys (AMED) Tops Q1 EPS by 6c
Tweet
Share
E-mail
Get Alerts AMED Hot Sheet
Price: $100.99 --0%
Financial Fact:
Operating expenses: 347.24M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Operating expenses: 347.24M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q1 EPS of $0.47, $0.06 better than the analyst estimate of $0.41. Revenue for the quarter came in at $370.46 million versus the consensus estimate of $370.3 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Macy's (M) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY Guidance
- Labcorp sets long-term growth targets at investor day
- Chewy (CHWY) Reports In-Line Q2 EPS, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
